Clinical Trials Directory

Trials / Completed

CompletedNCT05128227

PHARM-S.A.V.E.S: Suicide Prevention Training

PHARM-S.A.V.E.S: Suicide Prevention Gatekeeper Training for Pharmacy Staff

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
119 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.

Detailed description

This is a prospective pilot RCT that will evaluate the impact of suicide prevention gatekeeper training (Pharm-SAVES) on 150 pharmacy staff member communication behaviors (primary outcome). Data will be collected at baseline, immediately after training is completed, and at 1-month follow up. Data sources include simulated patient observations (to rate quality of communication) and survey data (for self-reports of knowledge, self-efficacy, and referral behaviors).

Conditions

Interventions

TypeNameDescription
BEHAVIORALPharm-SAVESA 30 minute long online module with videos and didactic content that covers the following topics: warning signs of suicide, how to ask a patient if they are contemplating suicide, and how to refer a patient to the Crisis Line. Three videos model patient scenarios of suicidal behavior in pharmacy settings including the pharmacy drive through, over the phone, and in person. Participants will receive continuing education credits (CEUs) (0.1 CEUs) for completing the course.
BEHAVIORALInteractive video casesTwo video interactive cases (approximately 10-minutes combined total) ask participants to complete open and close-ended questions about patients who exhibit suicidal behavior at the pharmacy. Participants will receive continuing education credits (0.1 CEUs) for completing the course.

Timeline

Start date
2022-04-15
Primary completion
2023-05-31
Completion
2023-06-01
First posted
2021-11-19
Last updated
2023-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05128227. Inclusion in this directory is not an endorsement.